iloprost
Term · Oncology and biomedicine · MLC-T-ONC-004169
A substance that is being studied in the prevention of lung cancer. It belongs to the family of drugs called prostaglandin analogs.
A prostacyclin analogue with potential chemopreventive activity. Iloprost binds to the prostacyclin receptor in various target cells, thereby causing vasodilation, inhibition of platelet aggregation, and decreased tumor cell adhesion to endothelium among other effects. Prostacyclin is a naturally occurring eicosanoid with anti-inflammatory, antineoplastic, and anti-metastatic properties.
| Identifier | MLC-T-ONC-004169 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Ciloprost; iloprost clathrate |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-004169",
"term": "iloprost",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that is being studied in the prevention of lung cancer. It belongs to the family of drugs called prostaglandin analogs.",
"A prostacyclin analogue with potential chemopreventive activity. Iloprost binds to the prostacyclin receptor in various target cells, thereby causing vasodilation, inhibition of platelet aggregation, and decreased tumor cell adhesion to endothelium among other effects. Prostacyclin is a naturally occurring eicosanoid with anti-inflammatory, antineoplastic, and anti-metastatic properties."
],
"synonyms": [
"Ciloprost",
"iloprost clathrate"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/iloprost/"
}
Record 9,027 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.